[London, 6 June 2024] – With deep, hassle-free, integration, Augnito is enabling continued transformation in radiology and supporting key solutions that will be showcased at UKIO 2024.

Taking place from 10th-12th June 2024 in Liverpool, the UK Imaging and Oncology (UKIO) congress is where leaders from across radiology come together to share best practice, discuss trends, undertake professional development, and learn about the latest state-of-the-art equipment and technology. The 2024 event will focus on the theme of ‘Vision and Values: Putting People First’.

Thanks to robust partnerships and extensive integration with leading platforms, Augnito speech recognition from Scribetech will be present at the event for the fourth year running.

“Nothing is more important to us than elevating fields across healthcare, and radiology is a particular focus,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito. “Augnito Spectra, our own highly convenient frontend across desktop and mobile, is part of this approach, but integration is equally important. Technology providers understand the potential of speech recognition as an accessible way for healthcare to leverage the potential of AI. Our partnerships with award-winning providers using Augnito Voice Services to speech enable their platforms is key to how, together, we can bring the benefits of speech recognition to more radiologists.”

One of the solutions carrying Augnito Voice Services embedded inside is Intelerad’s InSight PACS,  adopted by over 250 NHS and private healthcare providers across the UK and Ireland. In February 2024, InSight PACS was recognised as a 2024 Best in KLAS: Global Software Report award winner. Crucially, this award was based on feedback from the solution’s users – the people who rely on radiology reporting technology every day.

Austin stated: “Clinical system developers and cloud imaging solution providers appreciate Augnito for its API and SDK allowing them to seamlessly add Voice Services to their offering. We’ve taken one-of-a-kind speech recognition, developed in partnership with clinicians, and made it easy to integrate into any existing diagnostics and radiology reporting platform. But what drives us is the response from radiologists. People have reported significant time savings, faster reports, and increased accuracy – all these benefits lead to smoother patient journeys and better outcomes. That’s what matters.”

Augnito is also integrated into Hexarad: Radiology Technology Innovator of the Year in the M&A Today Global Awards 2024. Hexarad was also awarded the Silver HSJ Partnership Award for Diagnostics Project of the Year for its partnership with the North West Anglia NHS Foundation Trust. This project led to estimated time savings of up to 80 minutes per patient. Meanwhile, teleradiologists reporting on behalf of the trust received images within 25 minutes compared to 45 minutes using the previous system.

Representatives from these leading imaging solutions award winners will be attending UKIO 2024, (Hexarad), and exhibiting (Intelerad) alongside other high profile Scribetech partners using Augnito to speech-enable their systems. Exhibitors include Aptvision Ltd – with their e-referral portal, delivering better patient outcomes and reducing workloads for medical staff, CIMAR UK Ltd – who has recently joined forces with NHS England to deliver the AI Development Platform Pilot at Royal Surrey NHS Foundation Trust that will then enable the deployment of AI in medical imaging across the NHS, Fujifilm Healthcare UK – has integrated Augnito into its Universal Reporting module and will be showing this at UKIO, as well as new ultrasound imaging innovations and live demonstrations on its DeepInsight AI technology, Magentus – with a new Managing Director at their UK helm and a team supporting more than 25 million imaging events each year across 700+ locations with its Cris Radiology Information System, and OpenRad Services UK Ltd – showcasing its cloud-based Augnito speech-enabled remote reporting platform that includes the functionalities of a PACS, RIS and diagnostic 3D visualisation as distinct subscription packages with secure access from anywhere and from any device.

This significant presence at UKIO reflects the continued growth of Augnito AI powered speech recognition across radiology.

Scribetech is also a member of AXREM, the UK trade association for suppliers of imaging and healthcare equipment. This gives the company insight into the current and emerging needs of radiologists and imaging professionals and helps ensure that its voice-driven AI powered and cloud based solution, Augnito, remains relevant, impactful and evolving in pace with demand.

“This will be the fourth year running, since launching Augnito technology, that it is being shown at UKIO through our partners,” added Austin. “And while Scribetech has been an approved NHS solutions provider for over two decades, we brought Augnito to the UK market as a disruptive technology because our vision was to democratise the use of speech recognition across the continuum of care. We knew Augnito provided the value advantage – a better and more cost effective way for healthcare professionals to leverage the cloud and AI, to easily transform their patient data workflows. Now, 30 months later, we’re supporting more than 2,000 UK radiologists who have switched to Augnito – through our partnerships – and many others directly. We couldn’t agree more with this year’s UKIO theme and message ‘Vision and Values: Putting People First’. The positive effect that the impact Augnito is having on radiologists, and on patient imaging and diagnostics reporting speaks for itself. ”

ENDS

For media enquiries, please contact [email protected]

Notes to editors
All company names and product names listed in this press release are trademarks and registered trademarks of their respective owners.

About Scribetech (UK) Ltd and Augnito
Scribetech (UK) Ltd is a clinical solutions innovator and official distributor of Augnito products in the UK and Ireland. The company co-developed Augnito with its sister company Augnito India Private Ltd fusing 20 years of highly accurate and secure transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own Deep Neural Network speech recognition engine with advanced voice AI technology. Augnito provides a secure, cloud-based, voice-driven AI clinical speech recognition product suite, offering fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings cost effective, seamless speech recognition to daily workflows and third-party clinical systems, quickly turning medical information into documentation that makes healthcare intelligence compliant and accessible where it is needed.

A key member of a hospital’s leadership team, Chief Finance Officers (CFOs) are responsible for the capital health of the organisation. However, their financial choices, planning and budgeting also affect the health of individuals and the wider population.

In a typical hospital, CFOs strive for financial stability through effective planning, reporting, and strategic decision making. From cashflow to contract negotiations, CFOs ensure that financial resources are used effectively to deliver the best possible levels of care and seamless patient journeys.

In recent years, the financial pressure on hospitals and NHS Trusts has intensified. Rising demand, increasing costs, an ageing population, and funding shortfalls all create new challenges for CFOs everywhere. The Health Foundation expects these factors to worsen over time. In this context, CFOs must constantly balance competing priorities—and invest in new technology in a way that delivers the best possible return.

Solving major pain points (for Chief Finance Officers)

Efficiency is an overarching priority for CFOs. Driven by robust cash releasing efficiency targets from the Government, every CFO needs to improve processes, meaningfully reduce operating costs, and still maintain the highest standards of quality and care. This all needs to be achieved while ensuring healthcare professionals feel supported, both financially and in terms of workflow. The cost of 2023’s NHS strikes is an estimated £1.5 billion and the impact on operating costs and patients is hard to measure in financial terms.

While there is no single solution for a hospital’s complex operational needs, we’re confident that investment in clinical speech recognition delivers measurable value to staff and patients —without restricting the agility and financial clarity CFOs need in order to keep pace with a changing market.

Reducing overheads and increasing efficiency

At the most fundamental level, highly accurate clinical speech recognition is more affordable than manual transcription services or adding headcount to keep up with medical administration demand. When healthcare professionals can capture accurate patient notes and reports faster and more intuitively, they can work more efficiently—in short, the same number of ‘heads’ can complete a larger number of reports in the same amount of time.

Equally, cloud-based medical speech recognition like Augnito Spectra helps keep costs down by removing the need to overhaul IT infrastructures, spend capital for on-premise hardware, or employ IT teams to conduct application maintenance and upgrades.

Leveraging the investments in legacy technology already made

New technology including clinical speech recognition can also help CFOs drive even more value from the investments they’ve already made in digitisation. With an exhaustive SDK and API, Augnito’s AI platform can be easily and seamlessly integrated into any clinical system, including Electronic Patient Records (EPR). This allows 99.9% accurate speech recognition to be embedded into existing workflows, making even older software faster, easier, and more intuitive to use. Augnito can bridge legacy technology with new functionality now, without the cost of replacement—and continue to integrate with new technology when the Trust is financially and operationally ready to adopt it.

Making investments now to deliver lasting value

Amid widespread economic uncertainty, it’s difficult for CFOs to support strategic investments in new technology unless they can validate the likelihood of long-term value. A cloud hosted speech recognition platform like Augnito Spectra is scalable by design, ensuring its time-saving benefits can easily be extended to new individuals, new teams, and any location. Augnito has the flexibility to support site-wide expansion over time.

Augnito also delivers continuous improvement through machine learning, resulting in a solution that perpetually improves, even as new medical vocabulary comes into use. With a self-improving cloud solution, there’s no need to rethink, replace, and reinvest in something new in a few years.

Improving organisational agility

Finally, the only effective way to navigate economic uncertainty and unpredictable spikes in demand is with agility and flexibility. CFOs know that long-term financial commitments only diminish their ability to flex in order to meet the market, the needs of the workforce, government priorities, and population health requirements.

Augnito enables agility in an individual sense—by making speech recognition available anywhere, on any device—but also in an organisational sense, with simple recurring costs, no need to spend your capital, and options to shrink or grow your usage as required. Augnito is designed to accommodate fluctuations in staffing levels with localised user license administration for full control and options to recycle licenses for new users.

Learn more about Augnito

See how Augnito Spectra creates lasting value for hospital CFOs. Request a demo, to see the benefits for yourself.

[London, 30 April 2024] – Strengthening its position as an innovator in the imaging community, Scribetech has joined AXREM, the UK trade association for suppliers of imaging and healthcare IT equipment.

As UK healthcare continues its process of innovation, transformation and digitalisation, collaboration is vital. IT and equipment providers have an important role to play in addressing the emerging needs of healthcare professionals, responding to market changes, and steering the sector in-line with regulatory and compliance expectations.

To play a more active role in this process and champion sophisticated clinical speech recognition solutions in diagnostics and imaging, Scribetech, creator of Augnito, has joined AXREM as a new member.

“We know speech recognition has been instrumental in changing how radiologists work, since their early adoption of the technology in the 1980’s; we also know how today’s advanced and highly accurate speech recognition, powered by AI, has the ability to really help healthcare transform,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito. “With an industry leading solution offering an easy and efficient way to transcribe and digitalise imaging and diagnostics reporting as well as full integration with clinical systems, it’s crucial that we maximise our engagement with the radiology community—not just the healthcare professionals we support, but other technology providers and regulators. Our membership of AXREM reflects our commitment to leading the conversation around the future of imaging and healthcare.”

Established as the Association of X-Ray Equipment Manufacturers, AXREM has evolved over the past few years as the nature of diagnostic imaging equipment has changed. Today, AXREM is the largest UK trade association for suppliers of diagnostic imaging, radiotherapy and patient monitoring equipment, bringing together over 60 member companies. AXREM represents almost all of the UK market and, as a result, is an influential voice to represent its members’ views at every level of healthcare.

AXREM membership provides industry validation for Augnito, increasing its credibility as a reliable, high-quality solution in the medical imaging market. Additionally, membership also opens up a number of significant strategic benefits for Scribetech as part of the imaging community.

AXREM members receive regular industry insights and expertise, allowing Augnito to remain relevant to the real requirements of radiologists. Members can also take part in opportunities to network and collaborate, opening doors to new ways to integrate leading technology with Augnito and vice versa, as well as forums to share best practice.

Together, these membership benefits increase Scribetech’s ability to position Augnito strategically in the marketplace, drive growth opportunities, foster innovation, and strengthen its competitive advantage.

Austin added: “AXREM and its other member organisations share our priorities, ambitions and the ultimate aim of improving patient care. As a member, we’re forging a closer connection to the rest of the radiology and imaging community. This includes consultants, radiologists and radiographers, but also technology providers who can benefit from how easily Augnito can be integrated into their solutions. As a result, we’re able to bring the benefits of accurate, AI-powered speech recognition to more solutions and existing workflows.”

Augnito offers 99.9% accurate speech recognition in dedicated software, including desktop apps, browser-based interfaces, and mobile apps. Augnito was also developed with connectivity and integration in mind, including a comprehensive API and SDK to add native speech to existing systems including EPRs.

Austin concluded: “We’re looking forward to cementing our position as the leading provider of speech recognition in radiology  and becoming part of the AXREM ecosystem.”

ENDS

Notes to editors

About Augnito from Scribetech (UK) Ltd
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere.

Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.

Visit www.scribetech.co.uk for more details. For media enquiries, please contact [email protected].

About AXREM
AXREM’s member companies supply most of the diagnostic medical imaging and radiotherapy equipment installed in UK hospitals. They work with Consultant Radiologists, Radiographers and Practitioners, Oncologists, and a wide range of healthcare professionals in delivering healthcare to patients using our technologies.

Our members have unique knowledge, experience and insight into the workflow and challenges faced by healthcare professionals on a day-to-day basis, which enables us to develop and offer innovative solutions to improve the speed and quality of diagnostic procedures and treatments with our aim of improving patient care. Although our members operate in a highly competitive commercial environment and in strict conformity with UK laws and regulations, certain issues such as this require focus and resolution on an industry-wide basis.

For further information about this press release please contact AXREM Chief Executive Officer – Sally Edgington

AXREM, Rotherwick House, 3 Thomas More Street, London, E1W 1YZ

E [email protected]  ¦  T 07717 058649  ¦  www.axrem.org.uk 

 

 

 

 

 

 

Above all else, healthcare is about people—the patients we care for and the people who deliver that care, from frontline staff to the senior leadership within an NHS Trust. Any technology is only as impactful as it is useful to those people on a day-to-day basis.

As we kick off a new year, NHS Trusts continue to face the same pressures that have been mounting since the pandemic and, in many cases, even earlier. There is continued pressure for NHS Trusts to meet government plans around patient outcomes, digitalisation, and innovation, but technology can often become an additional burden and a source of complexity.

As a mature technology now enriched by the power of artificial intelligence, smart speech recognition and transcription address the very real pain points felt by leaders across the NHS. Beginning a new series of posts on these roles and pain points, let’s look at some major questions, challenges and priorities faced by Chief Information Officers (CIO), Chief Clinical Information Officers (CCIO) and Chief Nursing Informatics Officers (CNIO)—and how speech can help.

Shared questions, pain points and benefits for technical leaders

While CIO, CCIO and CNIO roles are vastly different in practice, they share similar challenges when it comes to aligning workflows with new technology to enhance employee experience and patient care. Their roles depend on not just bringing in new technology, but also ensuring that technology is tailored to the realities of healthcare, targeted to addressing key pain points, and practical for healthcare professionals to use as part of their daily workflows.

How does technology actually support clinical decisions?

Patient safety and positive outcomes are key to CIOs, CNIOs and CCIOs—any technology must enable more timely or more accurate clinical decisions at the point of care. Highly accurate speech recognition like Augnito is objectively faster and more flexible than slow manual typing or waiting for outsourced transcription, enabling the flow of patient data and enriching decisions with more accurate, complete notes and reports.

How can speech work alongside other systems?

Interoperability between different health IT systems is a key responsibility for CCIOs and CIOs, particularly around integration with often outdated legacy systems. Cloud-based speech recognition can integrate easily with existing Hospital Information Systems (HIS), Electronic Health Records (EHR), and other applications. Crucially, a robust cloud platform like Augnito also offers continuous updates, ensuring interoperability with new systems and applications as they emerge and adoption increases.

Where should a limited budget be focused?

One of the most acute pain points for CIOs, CCIOs and CNIOs—and, indeed, the entire NHS—is a limited IT budget that seems almost contradictory to the governmental pressure to make healthcare more digital. Balancing the need for innovation with financial constraints is a delicate task, but one that a pay-as-you-go cloud-based solution can help with. Significantly, Augnito allows Trusts to scale their usage up and down to meet their requirements and doesn’t require costly changes to your on-premise IT infrastructure. Beyond protecting capital, Augnito also removes the ongoing expense of burdensome management, maintenance, and updates.

How can we drive adoption—and maximise the impact?

CIOs, CCIOs and CNIOs all face huge resistance to new technology, new ways of working, and adoption. Nursing staff may resist adoption new technology due to concerns about disruption; entire organisations may ignore a new tool if they can’t clearly see the benefits for themselves. That’s why we developed Augnito with a relentless focus on ease of use and real-time results. It’s easy to try Augnito on a desktop, laptop, or mobile device, and instantly see the potential of 99.3% accurate speech-to-text. And this simplicity and flexibility creates a positive feedback loop where adoption by some leads to adoption by all—and ultimately a faster return on your investment.

Learn more about Augnito

See how Augnito Spectra delivers measurable benefits now while future-proofing the way you capture patient data. Request a demo or try Augnito Spectra for 7 days and see the benefits for yourself.

As we look back on 2023, we are reflecting on the topics that have been front of mind for every healthcare professional. For many, 2023 was another year of intense pressure, limited resources, and searching for ways to work more efficiently and improve the patient journey.

Throughout the year, we have considered many of the most significant, complex issues facing the NHS today. From Delayed Transfers of Care to understanding the real cost—and value—of new technology, we have discussed how AI-powered speech recognition can dramatically improve workloads and, ultimately, patient outcomes.

But how much has changed since we first discussed these important topics? And how can speech continue to deliver measurable value to healthcare professionals across every discipline and specialism?

The continued pressure of bed shortages

Back in January 2023, we wrote about the relationship between dwindling bed stocks, high occupancy rates, and Delayed Transfers of Care. Initiatives like the Urgent and Emergency Care Plan laid the foundation for improvement over time, but almost 12 months later, the number of available beds across the NHS remains low.

In December 2023, the NHS Confederation was reportedly ‘worried’ about the continued lack of beds, particularly in Yorkshire and north-east England. With occupancy hitting heights of 95%, Trusts are left exposed to surging flu rates and seasonal illnesses. At the same time, high occupancy also drives infection risk, potentially worsening an already fraught situation.

Speech recognition solutions like Augnito Spectra have a role to play in accelerating safe discharge by reducing internal delays. When clinical workfllows and reporting are fast, flexible and accurate, patients can be safely transferred outside of the NHS, freeing up vital bed space for someone else.

A national emergency for mental healthcare

We also discussed the current state of mental health services in the UK, describing a flashpoint where the available resources need to be rapidly expanded to keep up with surging demand. Sadly, more recent news articles suggest a system that’s perpetually struggling to keep up.

According to The Guardian, the NHS Confederation described mental healthcare in England as a ‘national emergency’ in October 2023. Many NHS leaders observe that mental health has ‘slipped down the government’s set of priorities’, with patients suffering as a result. The situation is similar across the wider UK—in Scotland’s December 2023 budget, mental health funding was cut by almost £30 million.

For mental health professionals (MHPs), new ways of working can enable manual tasks to be completed faster and more flexibly. Crucially, a speech recognition platform, like Augnito, enables MHPs to capture notes in a way that’s natural and intuitive, so more attention can be paid to important patient interactions and those personal, often difficult and emotional conversations.

The continued evolution of patient data

Finally, we looked at patient data in its various formats across 2023. We discussed the importance of interoperability, sharing patient data securely to enable collaboration across multi-disciplinary teams (MDTs). We also tracked the evolution of patient data, including the changing nature of patient records and the heightened importance of accuracy and clarity.

Despite some controversy around privacy, 2024 will undoubtedly see new changes in the way patient data is stored, captured, shared and processed.

Augnito Voice Services and Augnito Spectra will continue to deliver wide-reaching benefits across healthcare with 99.3% accurate, AI-powered transcription that’s available anywhere, on any device. Our aim in 2024 will focus even more on how Augnito modernises the way healthcare professionals report, so, in turn, patient journeys and experiences can be modernised too. All in a single cloud-hosted platform that can be integrated into your EPR system for secure sharing.

Increasingly, patient journeys are becoming digital journeys—and the quality of the data you hold is key.

Learn more about Augnito

See how Augnito Spectra delivers measurable benefits now while future-proofing the way you capture patient data. Request a demo or try Augnito Spectra for 7 days and see the benefits for yourself.